- Home
- KNSA vs PENN Comparison
KNSA vs PENN Comparison
Compare KNSA & PENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- PENN
- Stock Information
- Founded
- KNSA 2015
- PENN 1972
- Country
- KNSA United Kingdom
- PENN United States
- Employees
- KNSA N/A
- PENN N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- PENN Hotels/Resorts
- Sector
- KNSA Health Care
- PENN Consumer Discretionary
- Exchange
- KNSA Nasdaq
- PENN Nasdaq
- Market Cap
- KNSA 2.6B
- PENN 2.8B
- IPO Year
- KNSA 2018
- PENN 1994
- Fundamental
- Price
- KNSA $38.36
- PENN $14.47
- Analyst Decision
- KNSA Strong Buy
- PENN Buy
- Analyst Count
- KNSA 7
- PENN 16
- Target Price
- KNSA $49.71
- PENN $22.93
- AVG Volume (30 Days)
- KNSA 546.2K
- PENN 3.7M
- Earning Date
- KNSA 10-28-2025
- PENN 11-06-2025
- Dividend Yield
- KNSA N/A
- PENN N/A
- EPS Growth
- KNSA N/A
- PENN N/A
- EPS
- KNSA 0.47
- PENN N/A
- Revenue
- KNSA $597,973,000.00
- PENN $6,823,800,000.00
- Revenue This Year
- KNSA $62.63
- PENN $8.36
- Revenue Next Year
- KNSA $29.93
- PENN $5.50
- P/E Ratio
- KNSA $82.19
- PENN N/A
- Revenue Growth
- KNSA 55.68
- PENN 8.24
- 52 Week Low
- KNSA $17.82
- PENN $13.25
- 52 Week High
- KNSA $42.05
- PENN $23.08
- Technical
- Relative Strength Index (RSI)
- KNSA 52.71
- PENN 28.02
- Support Level
- KNSA $36.56
- PENN $15.98
- Resistance Level
- KNSA $39.66
- PENN $17.88
- Average True Range (ATR)
- KNSA 1.58
- PENN 0.78
- MACD
- KNSA -0.13
- PENN -0.22
- Stochastic Oscillator
- KNSA 50.78
- PENN 6.91
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.